CC
Casdin Capital Portfolio holdings
AUM
$1.1B
This Quarter Return
+60%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$1.07B
AUM Growth
+$1.07B
(+11%)
Cap. Flow
-$105M
Cap. Flow
% of AUM
-9.81%
Top 10 Holdings %
Top 10 Hldgs %
63.08%
Holding
35
New
1
Increased
10
Reduced
8
Closed
3
Top Buys
| 1 |
BLUE
bluebird bio
BLUE
|
$31.4M |
| 2 |
Denali Therapeutics
DNLI
|
$10.5M |
| 3 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$9.65M |
| 4 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$7.01M |
| 5 |
Fulcrum Therapeutics
FULC
|
$6.57M |
Top Sells
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$83.7M |
| 2 |
Sarepta Therapeutics
SRPT
|
$27.1M |
| 3 |
Q32 Bio
QTTB
|
$14.8M |
| 4 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$14.7M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$12.3M |
Sector Composition
| 1 | Healthcare | 92.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Sarepta Therapeutics
SRPT
$1.78B
| $86.5M | 7.95% | 670,000 -210,000 | -24% | -$27.1M |
|
|
BLUE
2
DELISTED
bluebird bio
BLUE
| $85.1M | 7.83% | 970,000 +357,500 | +58% | +$31.4M |
|
3
Codexis
CDXS
$246M
| $81.1M | 7.46% | 5,073,780 | – | – |
|
|
BPMC
4
DELISTED
Blueprint Medicines
BPMC
| $75.3M | 6.92% | 940,000 | – | – |
|
|
MYOK
5
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $73.2M | 6.74% | 1,005,000 -110,000 | -10% | -$8.02M |
|
6
Alnylam Pharmaceuticals
ALNY
$58.5B
| $59.3M | 5.45% | 515,000 -85,000 | -14% | -$9.79M |
|
|
NVTA
7
DELISTED
Invitae Corporation
NVTA
| $58.7M | 5.4% | 3,638,388 -200,000 | -5% | -$3.23M |
|
|
CNST
8
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $57.1M | 5.25% | 1,212,734 -311,226 | -20% | -$14.7M |
|
|
BOLD
9
DELISTED
Audentes Therapeutics, Inc
BOLD
| $51.5M | 4.73% | 860,000 | – | – |
|
10
Fate Therapeutics
FATE
$120M
| $49.9M | 4.59% | 2,550,000 | – | – |
|
11
Dianthus Therapeutics
DNTH
$759M
| $47M | 4.32% | 3,098,121 +50,000 | +2% | +$758K |
|
12
BioLife Solutions
BLFS
$1.2B
| $39.9M | 3.67% | 2,468,571 +40,000 | +2% | +$647K |
|
13
Agios Pharmaceuticals
AGIO
$2.19B
| $39.4M | 3.62% | 825,000 -110,000 | -12% | -$5.25M |
|
14
CareDx
CDNA
$727M
| $25.9M | 2.38% | 1,200,000 +200,000 | +20% | +$4.31M |
|
|
GBT
15
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $23.8M | 2.19% | 300,000 | – | – |
|
|
16
Denali Therapeutics
DNLI
$2.23B
| $21.8M | 2% | 1,250,000 +600,000 | +92% | +$10.5M |
|
|
17
Fulcrum Therapeutics
FULC
$351M
| $20.6M | 1.9% | 1,239,285 +395,000 | +47% | +$6.57M |
|
18
Illumina
ILMN
$15.8B
| $19.9M | 1.83% | 60,000 | – | – |
|
|
GRTS
19
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $19.4M | 1.78% | 2,160,000 +390,000 | +22% | +$3.5M |
|
20
Alector
ALEC
$238M
| $18.5M | 1.71% | 1,076,039 +265,000 | +33% | +$4.57M |
|
|
SAGE
21
DELISTED
Sage Therapeutics
SAGE
| $16.6M | 1.53% | 230,000 -170,000 | -43% | -$12.3M |
|
|
GNMK
22
DELISTED
GenMark Diagnostics, Inc
GNMK
| $16.2M | 1.49% | 3,365,000 | – | – |
|
|
DCPH
23
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $15.9M | 1.46% | 255,000 +155,000 | +155% | +$9.65M |
|
24
Voyager Therapeutics
VYGR
$186M
| $15.3M | 1.4% | 1,095,075 -33,000 | -3% | -$460K |
|
25
Adaptive Biotechnologies
ADPT
$2.01B
| $13.9M | 1.27% | 463,125 | – | – |
|